Literature DB >> 23877571

Antibiotics-related adverse events in the infectious diseases department of a French teaching hospital: a prospective study.

J Courjon1, C Pulcini, E Cua, K Risso, F Guillouet, E Bernard, P-M Roger.   

Abstract

Antibiotics are a significant cause of adverse events (AE), but few studies have focused on prescriptions in hospitalized patients. In infectious diseases departments, the high frequency and diversity of antibiotics prescribed makes AE post-marketing monitoring easier. The aim of our study was to assess the incidence and type of AE in the infectious diseases department of a French teaching tertiary-care hospital. The main characteristics of each hospitalization, including all antibiotics prescribed and any significant AE were recorded prospectively in the medical dashboard of the department. We included all patients having suffered an AE due to systemic antibiotics between January 2008 and March 2011. Among the 3963 hospitalized patients, 2682 (68%) received an antibiotic and 151/2682 (5.6%) suffered an AE. Fifty-two (34%) AE were gastrointestinal disorders, 32 (21%) dermatological, 20 (13%) hepatobiliary, 16 (11%) renal and urinary disorders, 13 (9%) neurological and 11 (7%) blood disorders. Rifampin, fosfomycin, cotrimoxazole and linezolid were the leading causes of AE. Sixty-two percent of the antibiotics causing an AE were stopped and 38% were continued (including 11% with a dose modification). Patients suffering from AE had an increased length of stay (18 vs 10 days, P < 0.001). Our data could help choosing the safest antibiotic when several options are possible.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23877571     DOI: 10.1007/s10096-013-1920-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  23 in total

Review 1.  Pulmonary infections in HIV-infected patients: an update in the 21st century.

Authors:  N Benito; A Moreno; J M Miro; A Torres
Journal:  Eur Respir J       Date:  2011-09-01       Impact factor: 16.671

2.  Hospitalization for serious blood and skin disorders following use of co-trimoxazole.

Authors:  M W Myers; H Jick
Journal:  Br J Clin Pharmacol       Date:  1997-04       Impact factor: 4.335

3.  National surveillance of emergency department visits for outpatient adverse drug events.

Authors:  Daniel S Budnitz; Daniel A Pollock; Kelly N Weidenbach; Aaron B Mendelsohn; Thomas J Schroeder; Joseph L Annest
Journal:  JAMA       Date:  2006-10-18       Impact factor: 56.272

4.  Increased drug reactions in HIV-1-positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV-1 disease. The Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).

Authors:  K J Smith; H G Skelton; J Yeager; R Ledsky; T H Ng; K F Wagner
Journal:  Clin Exp Dermatol       Date:  1997-05       Impact factor: 3.470

5.  Acute kidney injury associated with trimethoprim/sulfamethoxazole.

Authors:  Traci Nicole Fraser; Andres A Avellaneda; Edward A Graviss; Daniel M Musher
Journal:  J Antimicrob Chemother       Date:  2012-02-20       Impact factor: 5.790

6.  Emergency department visits for antibiotic-associated adverse events.

Authors:  Nadine Shehab; Priti R Patel; Arjun Srinivasan; Daniel S Budnitz
Journal:  Clin Infect Dis       Date:  2008-09-15       Impact factor: 9.079

7.  Trends and determinants of severe morbidity in HIV-infected patients: the ANRS CO3 Aquitaine Cohort, 2000-2004.

Authors:  F Bonnet; G Chêne; R Thiébaut; M Dupon; S Lawson-Ayayi; J L Pellegrin; F Dabis; P Morlat
Journal:  HIV Med       Date:  2007-11       Impact factor: 3.180

Review 8.  Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis.

Authors:  Bradley C Johnston; Stephanie S Y Ma; Joshua Z Goldenberg; Kristian Thorlund; Per O Vandvik; Mark Loeb; Gordon H Guyatt
Journal:  Ann Intern Med       Date:  2012-12-18       Impact factor: 25.391

9.  Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study.

Authors:  Tony Antoniou; Tara Gomes; Muhammad M Mamdani; Zhan Yao; Chelsea Hellings; Amit X Garg; Matthew A Weir; David N Juurlink
Journal:  BMJ       Date:  2011-09-12

Review 10.  Hepatic safety of antibiotics used in primary care.

Authors:  Raúl J Andrade; Paul M Tulkens
Journal:  J Antimicrob Chemother       Date:  2011-05-17       Impact factor: 5.790

View more
  6 in total

1.  Developing Mobile Clinical Decision Support for Nursing Home Staff Assessment of Urinary Tract Infection using Goal-Directed Design.

Authors:  Wallace Jones; Cynthia Drake; David Mack; Blaine Reeder; Barbara Trautner; Heidi Wald
Journal:  Appl Clin Inform       Date:  2017-06-20       Impact factor: 2.342

2.  Community-acquired pneumonia: impact of empirical antibiotic therapy without respiratory fluoroquinolones nor third-generation cephalosporins.

Authors:  J Pradelli; K Risso; F G de Salvador; E Cua; R Ruimy; P-M Roger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-10-02       Impact factor: 3.267

3.  Efficacy and safety of clindamycin-based treatment for bone and joint infections: a cohort study.

Authors:  J Courjon; E Demonchy; E Cua; E Bernard; P-M Roger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-09-07       Impact factor: 3.267

4.  Why is asymptomatic bacteriuria overtreated?: A tertiary care institutional survey of resident physicians.

Authors:  Myung Jin Lee; Moonsuk Kim; Nak-Hyun Kim; Chung-Jong Kim; Kyoung-Ho Song; Pyoeng Gyun Choe; Wan Beom Park; Ji Hwan Bang; Eu Suk Kim; Sang Won Park; Nam Joong Kim; Myoung-Don Oh; Hong Bin Kim
Journal:  BMC Infect Dis       Date:  2015-07-26       Impact factor: 3.090

5.  Inappropriate Management of Asymptomatic Patients With Positive Urine Cultures: A Systematic Review and Meta-analysis.

Authors:  Myrto Eleni Flokas; Nikolaos Andreatos; Michail Alevizakos; Alireza Kalbasi; Pelin Onur; Eleftherios Mylonakis
Journal:  Open Forum Infect Dis       Date:  2017-11-20       Impact factor: 3.835

6.  Antibiotic-associated suspected adverse drug reactions among hospitalized patients in Uganda: a prospective cohort study.

Authors:  Ronald Kiguba; Charles Karamagi; Sheila M Bird
Journal:  Pharmacol Res Perspect       Date:  2017-02-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.